Incidence of Drug Use–Related Endogenous Endophthalmitis Hospitalizations in the United States, 2003 to 2016
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 139 (1) , 18-26
Abstract
Endogenous endophthalmitis is a vision-threatening intraocular infection caused by hematogenous spread of pathogens to the retina and choroid, with eventual involvement of the vitreous.1 It is a rare condition and accounts for 2% to 15% of all cases of endophthalmitis.2-4 Despite advances in antibiotic therapy, the associated visual outcomes remain poor.2,3,5-11 Most patients have underlying risk factors for hematogenous infections, which in turn predispose to intraocular infection. Common systemic risk factors include diabetes, intravenous (IV) drug use, immunosuppression, and malignancy.2Keywords
This publication has 18 references indexed in Scilit:
- Systematic review of 342 cases of endogenous bacterial endophthalmitisSurvey of Ophthalmology, 2014
- ENDOGENOUS ENDOPHTHALMITIS ASSOCIATED WITH INTRAVENOUS DRUG ABUSERetina, 2014
- ENDOGENOUS ENDOPHTHALMITIS IN THE KOREAN POPULATIONRetina, 2014
- Endogenous endophthalmitis: 10-year experience at a tertiary referral centreEye, 2010
- Endogenous Endophthalmitis: A 10-year Review of Culture-positive Cases in Northern ChinaOcular Immunology and Inflammation, 2010
- Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomesAmerican Journal of Ophthalmology, 2004
- Endogenous EndophthalmitisMedicine, 2003
- Endogenous endophthalmitisCurrent Opinion in Ophthalmology, 2001
- Endogenous Bacterial EndophthalmitisOphthalmology, 1994
- Metastatic bacterial endophthalmitis: A contemporary reappraisalSurvey of Ophthalmology, 1986